Free Content Whole-genome profiling of chromosomal aberrations in hepatoblastoma using high-density single-nucleotide polymorphism genotyping microarrays

Authors: Suzuki, Makoto; Kato, Motohiro1; Yuyan, Chen1; Takita, Junko2; Sanada, Masashi3; Nannya, Yasuhito3; Yamamoto, Go3; Takahashi, Atsushi4; Ikeda, Hitoshi5; Kuwano, Hiroyuki4; Ogawa, Seishi; Hayashi, Yasuhide

Source: Cancer Science, Volume 99, Number 3, March 2008 , pp. 564-570(7)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

To identify the genomic profile and elucidate the pathogenesis of hepatoblastoma (HBL), the most common pediatric hepatic tumor, we performed high-density genome-wide single-nucleotide polymorphism (SNP) microarray analyses of 17 HBL samples. The copy number analyzer for GeneChip® (CNAG) and allele-specific copy number analysis using anonymous references (AsCNAR) algorithms enabled simple but sensitive inference of allelic composition without using paired normal DNA. Chromosomal aberrations were observed in 15 cases (88%). Gains in chromosomes 1q, 2 (or 2q), 8, 17q, and 20 and losses in chromosomes 4q and 11q were frequently identified. High-grade amplifications were detected at 7q34, 14q11.2, and 11q22.2. Several types of deletions, except homozygous deletion, were identified. Most importantly, copy-neutral loss of heterozygosity (uniparental disomy [UPD]) at 11p15 was detected in four of the 17 HBL samples. Insulin-like growth factor II (IGF2) and H19 genes were located within this region. The methylated status of this region indicated the paternal origin of the UPD. The expression patterns of IGF2 and H19 were opposite between genes with and without the UPD. This difference in the expression patterns might influence the clinical features of HBL. (Cancer Sci 2008; 99: 564-570)

Document Type: Research article

DOI: 10.1111/j.1349-7006.2007.00710.x

Affiliations: 1: Department of Pediatrics, 2: Department of Cell Therapy and Transplantation Medicine, 3: Department of Hematology and Oncology, and 4: Department of General Surgical Science, Graduate School of Medicine, Gunma University Graduate School, 3-39-15 Showa, Maebashi, Gunma 371-8511; 5: Department of Pediatric Surgery, Koshigaya Hospital, Dokkyo Medical School, 2-1-50 Minami-Koshigaya, Koshigaya, Saitama 343-8555;

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A